Wellington Management Group
PRME icon

Wellington Management Group’s Prime Medicine PRME Stock Holding History

Wellington Management Group’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$968K Buy
278,120
+29,893
+12% +$114K ﹤0.01% 1682
2025
Q4 		$861K Buy
248,227
+42,902
+21% +$191K ﹤0.01% 1738
2025
Q3 		$1.14M Buy
+205,325
New +$834K ﹤0.01% 1753
2024
Q3 		– Sell
-37,646
Closed -$194K – 2005
2024
Q2 		$194K Buy
+37,646
New +$228K ﹤0.01% 1866

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Wellington Management Group's PRME Position: Q1 2026 in Review

Wellington Management Group increased its Prime Medicine (PRME) stake by 12% in Q1 2026, buying an estimated $114K and bringing the position to 278,120 shares worth $968K. The position accounts for ﹤0.01% of the portfolio, ranked #1682.

Wellington Management Group first reported a position in PRME in Q2 2024 and has held it in 4 quarters since. The position peaked at $1.14M in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Wellington Management Group held 278,120 shares of Prime Medicine worth $968K as of Q1 2026.
  • Wellington Management Group bought 29,893 Prime Medicine shares in Q1 2026, an estimated $114K.
  • Prime Medicine made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1682 holding.
  • Wellington Management Group first reported a position in Prime Medicine in Q2 2024 and has held it in 4 quarters since.
  • Wellington Management Group's Prime Medicine position peaked at $1.14M in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.